Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00042679
Status:
COMPLETED
Last Update Posted:
2006-07-19
First Post:
2002-08-02
Brief Title:
A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha LY900003 ISIS 3521 Plus Gemcitabine and Carboplatin in Patients With Advanced Previously Untreated Non-Small Cell Lung Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Organization Data
Organization:
Eli Lilly and Company
Class:
INDUSTRY
Study ID:
6429
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eli Lilly and Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None